keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
Published 2 years ago • 925 plays • Length 7:18Download video MP4
Download video MP3
Similar videos
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
2:26
#esmo21 highlights on pembro chemo in 1st-line metastatic cervical cancer: the keynote-826 study
-
9:59
gs1-01: "phase 3 study of pembrolizumab chemotherapy vs placebo chemotherapy as neoadjuvant..."
-
0:46
gynecologic oncology at asco 2022: subgroup analysis of keynote-826
-
33:04
lecture 10c: cancer immunotherapy
-
24:01
what's new in cervical cancer: 2023 updates
-
1:00:06
restoring a sense of the greatness of god donald macleod 2
-
7:53
pembrolizumab for persistent, recurrent, or metastatic cervical cancer
-
0:56
keynote-a18: pembro or placebo with chemoradiotherapy in newly diagnosed high-risk cervical cancer
-
5:13
immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
-
6:38
pembrolizumab with chemotherapy as first line for metastatic cervical cancer
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
1:14
keynote-a18: pembrolizumab with chemoradiotherapy for advanced cervical cancer
-
1:38
keynote-a18: pembrolizumab chemoradiotherapy improves os in high-risk cervical cancer
-
3:04
keynote-024 update: pembrolizumab vs platinum-based chemotherapy in nsclc
-
6:32
latest results from keynote-181: pembrolizumab versus chemotherapy as a second-line therapy for ...
-
3:18
gynecologic oncology at esmo congress 2021: trial study in cervical cancer
-
2:55
how keytruda cancer treatment works (update)
-
1:19
novel immunotherapy-based combination approaches in cervical cancer
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
0:40
dr. joshua m. bauml on pembrolizumab versus chemo in head and neck cancers